IP Library › Granted Patent US 11,826,489
Granted Patent B2
US 11,826,489 · App. 17/519,109 · Granted Nov 28, 2023

Collagen scaffolds

Inventor: Martha M. Murray (Sherborn, MA)
Assignee: The Children's Medical Center Corporation
A61L27/24A61L27/3633A61L27/3691A61L27/56C07K14/78C12P21/00A61K38/00A61L2430/06A61L2430/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,826,489
App. No.
17/519,109
Granted
Nov 28, 2023
Kind
B2
Abstract

Methods for preparing and using collagen extracts and collagen scaffolds are provided. Additionally, methods and related kits for the repair of articular tissue using the collagen material are provided.

Claims (15)

1. A collagen implant configured to repair tissue exposed to synovial fluid, the collagen implant comprising:

an implant body having a size and shape that is configured for implantation into an articular joint where synovial fluid is present, the implant body entirely comprised of a self-assembly of collagen fibers, the self-assembly of collagen fibers having calcium, and including less than about 50,000 ng/g of DNA, less than about 5,000 uM/g of phospholipids, less than about 2,000 ug/g of GAG, less than about 25 ug/g of nucleic acids, wherein the collagen fibers are Type I collagen, and wherein the implant body is expandable and compressible and is capable of absorbing at least 3 ml of blood and has resistance to degradation by synovial fluid.

2. The collagen scaffold implant of claim 1 , wherein the Type I collagen is obtained from a bovine knee.

3. The collagen implant of claim 1 , wherein the self-assembly of collagen fibers comprises atelocollagen.

4. The collagen implant of claim 1 , wherein the self-assembly of collagen fibers further comprises a therapeutic protein.

5. The collagen implant of claim 1 , wherein the implant body has a first end, a second end opposed to the first end, and an outer wall that forms a generally cylindrical shape.

6. The collagen implant of claim 1 , wherein the implant is capable of absorbing at least 9 ml of blood.

7. The collagen implant of claim 1 , wherein the implant body is configured to permit a suture to pass therethrough.

8. The collagen implant of claim 1 , wherein the self-assembly of collagen fibers are substantially free of one or more of the following components: thrombin, non-autologous cellular components, active pepsin, and active virus.

9. The collagen implant of claim 7 , wherein the implant body is configured to be indirectly coupled to an anchor via the suture.

10. The collagen implant of claim 1 , wherein the collagen implant is a sponge.

11. The collagen implant of claim 1 , wherein the implant body is 22 mm in diameter.

12. The collagen implant of claim 1 , wherein the implant body is 30 mm in length.

13. The collagen implant of claim 1 , wherein the self-assembly of collagen fibers include greater than 100 ug/g of GAG.

14. The collagen implant of claim 1 , wherein the self-assembly of collagen fibers have a collagen concentration of greater than 10 mg/mL.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2022
From: MURRAY, MARTHA M.
To: THE CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 062177/0631 →
Continuity (5)
Division 16577890 · Sep 20, 2019
Continuation 15679629 · Aug 17, 2017
Continuation 14765064
Provisional Application 61759868 · Feb 1, 2013
Related Publication 20220096710A1 · Mar 31, 2022